ATE484579T1 - Infektiöse bursitis-virus mutanten und impfstoffe - Google Patents

Infektiöse bursitis-virus mutanten und impfstoffe

Info

Publication number
ATE484579T1
ATE484579T1 AT07114143T AT07114143T ATE484579T1 AT E484579 T1 ATE484579 T1 AT E484579T1 AT 07114143 T AT07114143 T AT 07114143T AT 07114143 T AT07114143 T AT 07114143T AT E484579 T1 ATE484579 T1 AT E484579T1
Authority
AT
Austria
Prior art keywords
vaccines
virus mutants
infectious bursitis
bursitis virus
infectious
Prior art date
Application number
AT07114143T
Other languages
English (en)
Inventor
Egbert Mundt
Tobias Letzel
Guntram Paul
Loon Adriaan Antonius Wilhelmus M Van
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Application granted granted Critical
Publication of ATE484579T1 publication Critical patent/ATE484579T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10061Methods of inactivation or attenuation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT07114143T 2003-03-24 2004-03-24 Infektiöse bursitis-virus mutanten und impfstoffe ATE484579T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03075842 2003-03-24

Publications (1)

Publication Number Publication Date
ATE484579T1 true ATE484579T1 (de) 2010-10-15

Family

ID=33041007

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07114143T ATE484579T1 (de) 2003-03-24 2004-03-24 Infektiöse bursitis-virus mutanten und impfstoffe

Country Status (13)

Country Link
EP (2) EP1908822B1 (de)
JP (1) JP4646903B2 (de)
KR (1) KR101085310B1 (de)
CN (1) CN100381565C (de)
AT (1) ATE484579T1 (de)
BR (1) BRPI0408643A (de)
CA (1) CA2520053A1 (de)
DE (1) DE602004029624D1 (de)
ES (1) ES2353429T3 (de)
MX (1) MXPA05010113A (de)
PL (1) PL1908822T3 (de)
RU (1) RU2340672C2 (de)
WO (1) WO2004085634A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1722814B1 (de) * 2004-03-12 2016-11-09 Zoetis Services LLC Antigene isolate und vakzine des infektiösen bursitis-virus
CN101054410B (zh) * 2005-03-29 2010-08-25 河南科技学院 鸡ibdv vp2蛋白中和性b细胞抗原表位ⅲ及其应用
CN1314706C (zh) * 2005-03-29 2007-05-09 河南科技学院 鸡ibdv vp2蛋白中和性b细胞抗原表位ⅱ及其应用
CN100384990C (zh) * 2005-11-14 2008-04-30 浙江大学 传染性法氏囊病病毒无毒力毒株构建方法
DE102011121069A1 (de) * 2011-12-13 2013-06-13 Martin-Luther-Universität Halle-Wittenberg Vakzinierung mittels rekombinanter Hefe durch Erzeugung einer protektiven humoralen Immunantwort gegen definierte Antigene
KR101511712B1 (ko) * 2013-04-03 2015-04-13 주식회사 카브 신규 전염성 f낭병 바이러스 ibd k7주 및 이를 이용한 전염성 f낭병 백신
RU2736888C2 (ru) * 2018-12-10 2020-11-23 Федеральное государственное бюджетное научное учреждение Федеральный научный центр "Всероссийский научно-исследовательский и технологический институт птицеводства" Российской академии наук Штамм "dd1" вируса инфекционной бурсальной болезни кур семейства birnaviridae, рода avibirnavirus, 1 серотипа для производства инактивированных сорбированных и эмульгированных вакцин

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788970A (en) * 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
CN1204251C (zh) * 2000-04-07 2005-06-01 浙江大学 传染性法氏囊病病毒(ibdv)主要宿主保护性抗原(vp2)基因生产vp2蛋白法及其基因工程
EP1170302B1 (de) * 2000-07-07 2006-06-21 Intervet International BV Impfstoffe basierend auf Mutanten des Virus der infektiösen Bursal-Krankheit
US6485940B2 (en) * 2000-07-07 2002-11-26 Akzo Nobel N.V. Broad spectrum infectious bursal disease virus vaccine

Also Published As

Publication number Publication date
MXPA05010113A (es) 2005-11-23
BRPI0408643A (pt) 2006-03-28
CA2520053A1 (en) 2004-10-07
CN100381565C (zh) 2008-04-16
WO2004085634A2 (en) 2004-10-07
EP1908822A3 (de) 2008-07-30
JP4646903B2 (ja) 2011-03-09
WO2004085634A3 (en) 2005-02-24
ES2353429T3 (es) 2011-03-02
EP1608741A2 (de) 2005-12-28
CN1764718A (zh) 2006-04-26
RU2340672C2 (ru) 2008-12-10
KR101085310B1 (ko) 2011-11-22
JP2006524046A (ja) 2006-10-26
EP1908822B1 (de) 2010-10-13
PL1908822T3 (pl) 2011-03-31
KR20050115929A (ko) 2005-12-08
RU2005132615A (ru) 2006-03-20
EP1908822A2 (de) 2008-04-09
DE602004029624D1 (de) 2010-11-25

Similar Documents

Publication Publication Date Title
DK1047784T3 (da) Neissera meningitidis-antigener
CY1110295T1 (el) Trans-9,10-δεϋδροεποθιλονη c και d, αναλογα αυτων και μεθοδοι παρασκευης
DE60335010D1 (de) Immunstimulatorische zusammensetzungen und verfahren zur stimulierung einer immunantwort
WO2004062597A3 (en) Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
CY1112862T1 (el) Θραυσματα μονοσθενους αντισωματος χρησιμα ως θεραπευτικα
WO2005032582A8 (en) Immunogenic compositions for streptococcus pyogenes
CY1108083T1 (el) Αντιγονα και συνθεσεις του neisseria meningitidis
WO2002081646A3 (en) Epitope sequences
DE69830579D1 (de) Chimäre impfstoffe gegen flaviviren
ZA200209047B (en) Process for permanently reshaping the hair using particular aminosilicones.
PL1648502T3 (pl) Szczepionki przeciwko HCV
ATE484579T1 (de) Infektiöse bursitis-virus mutanten und impfstoffe
AU2003206862A1 (en) Hepatitis b vaccines
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
DE69738271D1 (de) Rotavirus-impfstoff
AU2003261977A1 (en) Hbv precore protein capable of forming particles
MXPA03011117A (es) Anticuerpos recombinantes.
CL2010001175A1 (es) Composicion de vacuna que comprende un antigeno de proteina viral 2 (vp-2) del virus causante de la enfermedad de la bursitis infecciosa (ibdv).
ATE345532T1 (de) Datenübertragungsschnittstelle
WO2004032599A3 (en) Novel immunogenic proteins of leptospira
EP1426874A4 (de) Quellendatei-erzeugungsvorrichtung
AU2002257890A1 (en) Method for replicating the hepatitis C virus
AU2002310654A1 (en) Bursal disease virus-like particles
PL372453A1 (en) An infectious bursal disease virus variant
TW200636067A (en) Mutant porcine reproductive and respiratory syndrome virus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties